Cassell A, Yunusa B, Jalloh M, Ndoye M, Mbodji MM, Diallo A, et al. Management of advanced and metastatic prostate cancer: A need for a sub-saharan guideline. J Oncol. 2019; 2019: 1785428, CrossRef.
Kementrian Kesehatan Republik Indonesia [Internet]. Jakarta: Komite Penanggulangan Kanker Nasional; ©2015. Panduan Penatalaksanaan Kanker Prostat [cited 2024 June 22]. Available from: https://202.70.136.213/.
Garje R, Chennamadhavuni A, Mott SL, Chambers IM, Gellhaus P, Zakharia Y, et al. Utilization and outcomes of surgical castration in comparison to medical castration in metastatic prostate cancer. Clin Genitourin Cancer. 2020; 18(2): e157-66, CrossRef.
Ahn JS, Kwon EG, Lee HJ, Lee EM, Hwang SM, Cho SR, et al. Effect of hemi-castration on the productivity, histological characteristics, and economic efficacy of Korean beef cattle. Animals. 2021; 11(9): 2490,
Sidky SRI, Christopher PL, Dawn A, Baumann CW. Membrane proteins increase with the repeated bout effect. Med Sci Sports Exerc. 2022; 54(1): 57-66, CrossRef.
Brown AM, Ganjayi MS, Baumann CW. RAD140 (Testolone) negatively impacts skeletal muscle adaptation, frailty status and mortality risk in female mice. Clin Exp Pharmacol Physiol. 2023; 50(12): 973-83, CrossRef.
Miller CP, Shomali M, Lyttle CR, O'Dea LS, Herendeen H, Gallacher K, Paquin D, Compton DR, et al. Design, synthesis, and preclinical characterization of the selective androgen receptor modulator (SARM) RAD140. ACS Med Chem Lett. 2010; 2(2): 124-9, CrossRef.
Federer WT. Experimental Design, Theory and Application. New Delhi: Oxford & IBH Publishing Company. 1967, article.
Burmeister M, Fincher T, Graham WH. Recreational use of selective androgen receptor modulators. US Pharm. 2020; 45(60): 15-8, article.
Sophocleous A, Idris AI. Ovariectomy/orchiectomy in rodents. Methods Mol Biol. 2019; 1914: 261-7, CrossRef.
Gorczyca D, Kwiatkowska D. Duality nature of selective androgen receptor modulators and specific steroids substance. Disaster Emerg Med J. 2019; 4(2): 60-2, CrossRef.
de Paiva Gonçalves V, Cabrera-Ortega AA, Carvalho JD, Ramadan D, Spolidorio LC. Physiological testosterone replacement effects on male aged rats with orchiectomy-induced osteoporosis in advanced stage: A tomographic and biomechanical pilot study. Aging Male. 2021; 24: 139-47, CrossRef.
Mohamad NV, Soelaiman IN, Chin KY. A concise review of testosterone and bone health. Clin Interv Aging 2016; 11: 1317-24, CrossRef.
Magdy A, Fahmy S, Mohamed A, Saad D, Desokyand R, Baiomy A, et al. Histopathological and immunohistochemical study of antiosteoporotic efficacy of the earthworm Allolobophora caliginosa extract in orchiectomized rats. Int J Morphol 2022; 40(1): 277-86, CrossRef.
Chen L, Wang G, Wang Q, Liu Q, Sun Q, Chen L. N-acetylcysteine prevents orchiectomy-induced osteoporosis by inhibiting oxidative stress and osteocyte senescence. Am J Transl Res. 2019; 11(7): 4337-47, article.
Efimenko IV, Valancy D, Dubin JM, Ramasamy R. Adverse effects and potential benefits among selective androgen receptor modulators users: a cross-sectional survey. Int J Impot Res. 2022; 34(8):757-61, CrossRef.
Kearbey JD, Gao W, Narayanan R, Fisher SJ, Wu D, Miller DD, et al. Selective androgen receptor modulator (SARM) treatment prevents bone loss and reduces body fat in ovariectomized rats. Pharm Res. 2007; 24(2): 328-35, CrossRef.
Gao W, Reiser PJ, Coss CC, Phelps MA, Kearbey JD, Miller DD, et al. Selective androgen receptor modulator treatment improves muscle strength and body composition and prevents bone loss in orchidectomized rats. Endocrinology. 2005; 146(11): 4887-97, CrossRef.
Dubois V, Laurent M, Boonen S, Vanderschueren D, Claessens F. Androgens and skeletal muscle: Cellular and molecular action mechanisms underlying the anabolic actions. Cell Mol Life Sci. 2012; 69(10):1651-67, CrossRef.
Singh R, Bhasin S, Braga M, Artaza JN, Pervin S, Taylor WE, et al. Regulation of myogenic differentiation by androgens: Cross talk between androgen receptor/ beta-catenin and follistatin/transforming growth factor-beta signaling pathways. Endocrinology. 2009; 150(3): 1259-68, CrossRef.
Bhasin S, Jasuja R. Selective androgen receptor modulators as function promoting therapies. Curr Opin Clin Nutr Metab Care. 2009; 12(3): 232-40, CrossRef.
Morimoto M, Amano Y, Oka M, Harada A, Fujita H, Hikichi Y, et al. Amelioration of sexual behavior and motor activity deficits in a castrated rodent model with a selective androgen receptor modulator SARM-2f. Plos One. 2017; 12(12): e0189480, CrossRef.
Simitsidellis I, Esnal-Zuffiaure A, Kelepouri O, O'Flaherty E, Gibson DA, Saunders PTK. Selective androgen receptor modulators (SARMs) have specific impacts on the mouse uterus. J Endocrinol. 2019; 242(3): 227-39, CrossRef.
Dalton JT, Barnette KG, Bohl CE, Hancock ML, Rodriguez D, Dodson ST, et al. The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: Results of a double-blind, placebo-controlled phase II trial. J Cachexia Sarcopenia Muscle. 2011; 2(3): 153-61, CrossRef.
Davey RA, Grossmann M. Androgen receptor structure, function and biology: From bench to bedside. Clin Biochem Rev. 2016; 37(1): 3-15, article.
Davidyan A, Pathak S, Baar K, Bodine SC. Maintenance of muscle mass in adult male rats is independent of testosterone. Plos One. 2021; 16(3): e0240278, CrossRef.
Nguyen PL, Alibhai SM, Basaria S, D'Amico AV, Kantoff PW, Keating NL, et al. Adverse effects of androgen deprivation therapy and strategies to mitigate them. Eur Urol. 2015; 67(5): 825-36, CrossRef.